A new drug (N-acetyl cysteine eye drops) before corneal transplant for Fuchs Endothelial Corneal Dystrophy

You may qualify if

• Male or female ≥21 years of age at time of surgical evaluation.
• Diagnosis of advanced FECD and visually significant cataract
• Indication for DMEK (Descemet Membrane Endothelial Keratoplasty) with concurrent cataract surgery
• Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
• Willingness and ability to adhere to medication regimen

You can't join if

• Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study.
• History of prior intraocular surgery in study eye including cataract, glaucoma and/or retina surgery
• History of other corneal diseases, such as severe dry eye, corneal scars, pseudophakic bullous keratopathy, corneal degenerations, corneal infections
• Use of ocular prescription medications except for lubricants, hyperosmotic agents, or ocular hypotensive agents
• History of ocular surface infection within the past 30 days
• Use of systemic, inhalational, or topical N-Acetylcysteine within the past 30 days
• History of intolerance to topical N-Acetylcysteine
• Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. -